Trial results extend add to uses for Exact Sciences test December 28, 2020 Auto Bot biopharma nl, breast cancer, Cancer Diagnostics, Diagnostics, Exact Sciences, News, Wisconsin 0 The genomic test, known as Oncotype DX, can help predict whether women with certain forms of breast cancer will benefit from chemotherapy — and those who won’t. The latest trial results extend the test’s reach.